发明申请
- 专利标题： Novel Sulfonaminoquinoline Hepcidin Antagonists
- 专利标题（中）： 新型磺酰氨基喹啉Hepcidin拮抗剂
-
申请号： US14310254申请日： 2014-06-20
-
公开(公告)号： US20140364424A1公开(公告)日： 2014-12-11
- 发明人: Wilm Buhr , Susanna Burckhardt , Franz Dürrenberger , Felix Funk , Peter O. Geisser , Vincent A. Corden , Stephen M. Courtney , Graham Dawson , Tara Davenport , Mark Slack , Mark P. Ridgill , Christopher J. Yarnold , Susan Boyce , Albertus A. Ellenbroek
- 申请人： Vifor (International) AG
- 优先权： EP11155103.2 20110218
- 主分类号： C07D513/04
- IPC分类号： C07D513/04 ; A61K45/06 ; C07D401/12 ; C07D409/12 ; C07D215/40
摘要：
The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.
公开/授权文献
- US09102688B2 Sulfonaminoquinoline hepcidin antagonists 公开/授权日：2015-08-11
信息查询
